Cumulative effect of prophage burden on Shiga toxin production in Escherichia coli

Microbiology

Volumn 158, Issue 2, 2012, Pages 488-497

  Fogg, Paul C M ^a   Saunders, Jon R ^a   Mccarthy, Alan J ^a   Allison, Heather E ^a,b  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DISEASE SEVERITY; GENE EXPRESSION; GENETIC TRANSCRIPTION; GENOME; IMMUNITY; LIFE CYCLE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROPHAGE; REPORTER GENE; SHIGA TOXIN PRODUCING ESCHERICHIA COLI;

BACTERIOPHAGES; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI O157; HUMANS; LYSOGENY; PROPHAGES; SHIGA TOXIN;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI;

EID: 84856741307     PISSN: 13500872     EISSN: None     Source Type: Journal    
DOI: 10.1099/mic.0.054981-0     Document Type: Article

References (60)

1. Allison, H. E. (2007). Stx-phages: drivers and mediators of the evolution of STEC and STEC-like pathogens. Future Microbiol 2, 165-174
2. Allison, H. E., Sergeant, M. J., James, C. E., Saunders, J. R., Smith, D. L., Sharp, R. J., Marks, T. S. & McCarthy, A. J. (2003). Immunity profiles of wild-type and recombinant Shiga-like toxin-encoding bacteriophages and characterization of novel double lysogens. Infect Immun 71, 3409-3418
3. Ashkenazi, S., Cleary, K. R., Pickering, L. K., Murray, B. E. & Cleary, T. G. (1990). The association of Shiga toxin and other cytotoxins with the neurologic manifestations of shigellosis. J Infect Dis 161, 961-965
4. Banatvala, N., Debeukelaer, M. M., Griffin, P. M., Barrett, T. J., Greene, K. D., Green, J. H. & Wells, J. G. (1996). Shiga-like toxinproducing Escherichia coli O111 and associated hemolytic-uremic syndrome: a family outbreak. Pediatr Infect Dis J 15, 1008-1011
5. Bielaszewska, M., Prager, R., Zhang, W., Friedrich, A.W., Mellmann, A., Tschäpe, H. & Karch, H. (2006). Chromosomal dynamism in progeny of outbreak-related sorbitol-fermenting enterohemorrhagic Escherichia coli O157:NM. Appl Environ Microbiol 72, 1900-1909
6. Bielaszewska, M., Prager, R., Köck, R., Mellmann, A., Zhang, W., Tschäpe, H., Tarr, P. I. & Karch, H. (2007). Shiga toxin gene loss and transfer in vitro and in vivo during enterohemorrhagic Escherichia coli O26 infection in humans. Appl Environ Microbiol 73, 3144-3150
7. Botstein, D. (1980). A theory of modular evolution for bacteriophages. Ann N Y Acad Sci 354, 484-490
8. Brockmann, R., Beyer, A., Heinisch, J. J. & Wilhelm, T. (2007). Posttranscriptional expression regulation: what determines translation rates? PLOS Comput Biol 3, e57.
9. Brüssow, H., Canchaya, C. & Hardt, W. D. (2004). Phages and the evolution of bacterial pathogens: from genomic rearrangements to lysogenic conversion. Microbiol Mol Biol Rev 68, 560-602
10. Cornick, N. A., Jelacic, S., Ciol, M. A. & Tarr, P. I. (2002). Escherichia coli O157:H7 infections: discordance between filterable fecal Shiga toxin and disease outcome. J Infect Dis 186, 57-63
11. Craig, N. L. & Roberts, J. W. (1980). E. coli RecA protein-directed cleavage of phage l repressor requires polynucleotide. Nature 283, 26-30
12. Díaz, R., Vargas-Lagunas, C., Villalobos, M. A., Peralta, H., Mora, Y., Encarnación, S., Girard, L. & Mora, J. (2011). argC orthologs from Rhizobiales show diverse profiles of transcriptional efficiency and functionality in Sinorhizobium meliloti. J Bacteriol 193, 460-472
13. Eklund, M., Leino, K. & Siitonen, A. (2002). Clinical Escherichia coli strains carrying stx genes: stx variants and stx-positive virulence profiles. J Clin Microbiol 40, 4585-4593
14. Elliott, E. J., Robins-Browne, R. M., O'Loughlin, E. V., Bennett-Wood, V., Bourke, J., Henning, P., Hogg, G. G., Knight, J., Powell, H., Redmond, D. & Contributors to the Australian Paediatric Surveillance Unit (2001). Nationwide study of haemolytic uraemic syndrome: clinical, microbiological, and epidemiological features. Arch Dis Child 85, 125-131
15. Fogg, P. C., Gossage, S. M., Smith, D. L., Saunders, J. R., McCarthy, A. J. & Allison, H. E. (2007). Identification of multiple integration sites for Stx-phage W24B in the Escherichia coli genome, description of a novel integrase and evidence for a functional anti-repressor. Microbiology 153, 4098-4110
16. Fogg, P. C. M., Allison, H. E., Saunders, J. R. & McCarthy, A. J. (2010). Bacteriophage lambda: a paradigm revisited. J Virol 84, 6876-6879
17. Fogg, P. C. M., Rigden, D. J., Saunders, J. R., McCarthy, A. J. & Allison, H. E. (2011). Characterization of the relationship between integrase, excisionase and antirepressor activities associated with a superinfecting Shiga toxin encoding bacteriophage. Nucleic Acids Res 39, 2116-2129
18. Gamage, S. D., Patton, A. K., Strasser, J. E., Chalk, C. L. & Weiss, A. A. (2006). Commensal bacteria influence Escherichia coli O157:H7 persistence and Shiga toxin production in the mouse intestine. Infect Immun 74, 1977-1983
19. Görg, A., Drews, O. & Weiss, W. (2006). Extraction and solubilization of total protein from microorganisms. Cold Spring Harb Protoc 2006, 4224.
20. Gyles, C. L. (2007). Shiga toxin-producing Escherichia coli: an overview. J Anim Sci 85 (Suppl.), E45-E62.
21. Hayashi, T., Makino, K., Ohnishi, M., Kurokawa, K., Ishii, K., Yokoyama, K., Han, C. G., Ohtsubo, E., Nakayama, K. & other authors (2001). Complete genome sequence of enterohemorrhagic Escherichia coli O157:H7 and genomic comparison with a laboratory strain K-12. DNA Res 8, 11-22
22. Heddle, J. G., Barnard, F. M., Wentzell, L. M. & Maxwell, A. (2000). The interaction of drugs with DNA gyrase: a model for the molecular basis of quinolone action. Nucleosides Nucleotides Nucleic Acids 19, 1249-1264
23. Herold, S., Karch, H. & Schmidt, H. (2004). Shiga toxin-encoding bacteriophages-genomes in motion. Int J Med Microbiol 294, 115-121
24. Herold, S., Siebert, J., Huber, A. & Schmidt, H. (2005). Global expression of prophage genes in Escherichia coli O157:H7 strainEDL933 in response to norfloxacin. Antimicrob Agents Chemother 49, 931-944
25. James, C. E., Stanley, K. N., Allison, H. E., Flint, H. J., Stewart, C. S., Sharp, R. J., Saunders, J. R. & McCarthy, A. J. (2001). Lytic and lysogenic infection of diverse Escherichia coli and Shigella strains with a verocytotoxigenic bacteriophage. Appl Environ Microbiol 67, 4335-4337
26. Kaper, J. B., Nataro, J. P. & Mobley, H. L. (2004). Pathogenic Escherichia coli. Nat Rev Microbiol 2, 123-140
27. King, A. J., Sundaram, S., Cendoroglo, M., Acheson, D. W. K. & Keusch, G. T. (1999). Shiga toxin induces superoxide production in polymorphonuclear cells with subsequent impairment of phagocytosis and responsiveness to phorbol esters. J Infect Dis 179, 503-507
28. Lainhart, W., Stolfa, G. & Koudelka, G. B. (2009). Shiga toxin as a bacterial defense against a eukaryotic predator, Tetrahymena thermophila. J Bacteriol 191, 5116-5122
29. Livak, K. J. & Schmittgen, T. D. (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2^DDCt method. Methods 25, 402-408
30. Loś, J. M., Loś, M., Wegrzyn, G. & Wegrzyn, A. (2009). Differential efficiency of induction of various lambdoid prophages responsible for production of Shiga toxins in response to different induction agents. Microb Pathog 47, 289-298
31. Loś, J. M., Loś, M., Wegrzyn, A. & Wegrzyn, G. (2010). Hydrogen peroxide-mediated induction of the Shiga toxin-converting lambdoid prophage ST2-8624 in Escherichia coli O157: H7. FEMS Immunol Med Microbiol 58, 322-329
32. Matsushiro, A., Sato, K., Miyamoto, H., Yamamura, T. & Honda, T. (1999). Induction of prophages of enterohemorrhagic Escherichia coli O157:H7 with norfloxacin. J Bacteriol 181, 2257-2260
33. Mühldorfer, I., Hacker, J., Keusch, G. T., Acheson, D. W., Tschäpe, H., Kane, A. V., Ritter, A., Olschlä ger, T. & Donohue-Rolfe, A. (1996). Regulation of the Shiga-like toxin II operon in Escherichia coli. Infect Immun 64, 495-502
34. Muniesa, M., de Simon, M., Prats, G., Ferrer, D., Pañella, H. & Jofre, J. (2003). Shiga toxin 2-converting bacteriophages associated with clonal variability in Escherichia coli O157:H7 strains of human origin isolated from a single outbreak. Infect Immun 71, 4554-4562
35. Neely, M. N. & Friedman, D. I. (1998). Functional and genetic analysis of regulatory regions of coliphage H-19B: location of Shiga-like toxin and lysis genes suggest a role for phage functions in toxin release. Mol Microbiol 28, 1255-1267
36. Neupane, M., Abu-Ali, G. S., Mitra, A., Lacher, D. W., Manning, S. D. & Riordan, J. T. (2011). Shiga toxin 2 overexpression in Escherichia coli O157:H7 strains associated with severe human disease. Microb Pathog 51, 466-470
37. Niebauer, R. T., Wedekind, A. & Robinson, A. S. (2004). Decreases in yeast expression yields of the human adenosine A2a receptor are a result of translational or post-translational events. Protein Expr Purif 37, 134-143
38. O'Brien, A. D., Newland, J. W., Miller, S. F., Holmes, R. K., Smith, H. W. & Formal, S. B. (1984). Shiga-like toxin-converting phages from Escherichia coli strains that cause hemorrhagic colitis or infantile diarrhea. Science 226, 694-696
39. O'Loughlin, E. V. & Robins-Browne, R. M. (2001). Effect of Shiga toxin and Shiga-like toxins on eukaryotic cells. Microbes Infect 3, 493-507
40. Perna, N. T., Plunkett, G., III, Burland, V., Mau, B., Glasner, J. D., Rose, D. J., Mayhew, G. F., Evans, P. S., Gregor, J. & other authors (2001). Genome sequence of enterohaemorrhagic Escherichia coli O157: H7. Nature 409, 529-533
41. Piddock, L. J. V. & Wise, R. (1987). Induction of the SOS response in Escherichia coli by 4-quinolone antimicrobial agents. FEMS Microbiol Lett 41, 289-294
42. Plunkett, G., III, Rose, D. J., Durfee, T. J. & Blattner, F. R. (1999). Sequence of Shiga toxin 2 phage 933W from Escherichia coli O157: H7: Shiga toxin as a phage late-gene product. J Bacteriol 181, 1767-1778
43. Poirier, K., Faucher, S. P., Beland, M., Brousseau, R., Gannon, V., Martin, C., Harel, J. & Daigle, F. (2008). Escherichia coli O157:H7 survives within human macrophages: global gene expression profile and involvement of the Shiga toxins. Infect Immun 76, 4814-4822
44. Ptashne, M. (2004). A Genetic Switch: Phage Lambda Revisited, 3rd edn. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory.
45. Riley, L. W., Remis, R. S., Helgerson, S. D., McGee, H. B., Wells, J. G., Davis, B. R., Hebert, R. J., Olcott, E. S., Johnson, L. M. & other authors (1983). Hemorrhagic colitis associated with a rare Escherichia coli serotype. N Engl J Med 308, 681-685
46. Serra-Moreno, R., Jofre, J. & Muniesa, M. (2008). The CI repressors of Shiga toxin-converting prophages are involved in coinfection of Escherichia coli strains, which causes a down regulation in the production of Shiga toxin 2. J Bacteriol 190, 4722-4735
47. Shimizu, T., Kawakami, S., Sato, T., Sasaki, T., Higashide, M., Hamabata, T., Ohta, T. & Noda, M. (2007). The serine 31 residue of the B subunit of Shiga toxin 2 is essential for secretion in enterohemorrhagic Escherichia coli. Infect Immun 75, 2189-2200
48. Shimizu, T., Ohta, Y. & Noda, M. (2009). Shiga toxin 2 is specifically released from bacterial cells by two different mechanisms. Infect Immun 77, 2813-2823
49. Spears, K. J., Roe, A. J. & Gally, D. L. (2006). A comparison of enteropathogenic and enterohaemorrhagic Escherichia coli pathogenesis. FEMS Microbiol Lett 255, 187-202
50. Strockbine, N. A., Marques, L. R., Newland, J. W., Smith, H. W., Holmes, R. K. & O'Brien, A. D. (1986). Two toxin-converting phages from Escherichia coli O157:H7 strain 933 encode antigenically distinct toxins with similar biologic activities. Infect Immun 53, 135-140
51. Sung, L. M., Jackson, M. P., O'Brien, A. D. & Holmes, R. K. (1990). Transcription of the Shiga-like toxin type II and Shiga-like toxin type II variant operons of Escherichia coli. J Bacteriol 172, 6386-6395
52. Tozzi, A. E., Caprioli, A., Minelli, F., Gianviti, A., De Petris, L., Edefonti, A., Montini, G., Ferretti, A., De Palo, T. & other authors (2003). Shiga toxin-producing Escherichia coli infections associated with hemolytic uremic syndrome, Italy, 1988-2000 Emerg Infect Dis 9, 106-108
53. Tyler, J. S., Mills, M. J. & Friedman, D. I. (2004). The operator and early promoter region of the Shiga toxin type 2-encoding bacteriophage 933W and control of toxin expression. J Bacteriol 186, 7670-7679
54. Wagner, P. L., Acheson, D. W. & Waldor, M. K. (1999). Isogenic lysogens of diverse Shiga toxin 2-encoding bacteriophages produce markedly different amounts of Shiga toxin. Infect Immun 67, 6710-6714
55. Wagner, P. L., Neely, M. N., Zhang, X., Acheson, D. W. K., Waldor, M. K. & Friedman, D. I. (2001). Role for a phage promoter in Shiga toxin 2 expression from a pathogenic Escherichia coli strain. J Bacteriol 183, 2081-2085
56. Wagner, P. L., Livny, J., Neely, M. N., Acheson, D. W. K., Friedman, D. I. & Waldor, M. K. (2002). Bacteriophage control of Shiga toxin 1 production and release by Escherichia coli. Mol Microbiol 44, 957-970
57. Walterspiel, J. N., Ashkenazi, S., Morrow, A. L. & Cleary, T. G. (1992). Effect of subinhibitory concentrations of antibiotics on extracellular Shiga-like toxin I. Infection 20, 25-29
58. Weinstein, D. L., Jackson, M. P., Perera, L. P., Holmes, R. K. & O'Brien, A. D. (1989). In vivo formation of hybrid toxins comprising Shiga toxin and the Shiga-like toxins and role of the B subunit in localization and cytotoxic activity. Infect Immun 57, 3743-3750
59. Woodward, D. L., Clark, C. G., Caldeira, R. A., Ahmed, R. & Rodgers, F. G. (2002). Verotoxigenic Escherichia coli (VTEC): a major public health threat in Canada. Can J Infect Dis Med Microbiol 13, 321-330
60. Zheng, J., Cui, S., Teel, L. D., Zhao, S., Singh, R., O'Brien, A. D. & Meng, J. (2008). Identification and characterization of Shiga toxin type 2 variants in Escherichia coli isolates from animals, food, and humans. Appl Environ Microbiol 74, 5645-5652.